Skip to content

Use of Ayurvedic Oil to Relieve Pain During Intimacy in Women Treated with Radiation for Gynecological Cancer - Phase I and Phase II study

A study to assess the effect of dyspareunia by ayurvedic oil in patients who have undergone radiation treatment for gynecological cancer at a tertiary cancer care centre, Mumbai Phase I and Phase Il study. Feasibility and Efficacy.

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092893
Enrollment
88
Registered
2025-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C52- Malignant neoplasm of vagina Health Condition 2: C519- Malignant neoplasm of vulva, unspecified Health Condition 3: C541- Malignant neoplasm of endometrium Health Condition 4: C55- Malignant neoplasm of uterus, partunspecified

Interventions

None listed

Sponsors

Raja Ramdeo Anandilal Podar Central Ayurveda Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women more than or is equal to 18 years of age with gynecological cancer that is cervical, endometrium, vulvar and vaginal 2. Who have undergone surgery like hysterectomy, BSOH and RPLND and adjuvant RT 3. EBRT up to 70 CGy alone or Brachytherapy alone or in combination. 4. EBRT up to 70 CGy plus or minus Brachytherapy plus or minus Concurrent chemo radiation 5. Post completion of 6 months of radiation treatment, till 18 months. 6. Who are sexually active or desirous of. 7. Who are willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients who are hypersensitive to Jatyadi oil. 2. Not interested or desirous of sexual activity,

Design outcomes

Primary

MeasureTime frame
To assess the feasibility of ayurvedic oil (Jatyadi oil) application on patients with dyspareunia who have undergone radiation treatment for gynecological cancers Phase I.Timepoint: Day 0 and Day 28

Secondary

MeasureTime frame
To find out the effect of ayurvedic oil (Jatyadi oil) on dyspareunia in control and experimental group in patients with gynecological cancer who have undergone radiation treatment Phase II. To know the association between the clinical data and dyspareunia Timepoint: Day 0 and Day 28

Countries

India

Contacts

Public ContactPunam Mungase

Tata Memorial Hospital

prathepa_jagadish@rediffmail.com09869220441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026